Merck Announces Additional $150M Investment Through 2025 to Help End Maternal Mortality Inequities

Press Release

KENILWORTH, N.J., January 10, 2022 /3BLMedia/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced an additional $150 million commitment through Merck for Mothers to further advance the initiative’s mission of helping create a world where no woman has to die giving life.

How Merck Is Prioritizing Supply

Learn how our teams mobilized like never before to ensure we were ready to address a global need
Multimedia with summary

From the earliest stages of the COVID-19 pandemic, we knew we had a responsibility to mobilize and innovate to rise to the challenge of this unique moment.

This is what we’re doing.

View the orginal content and the Merck infographic here.  

Showing Our Gratitude: Addressing COVID-19 Takes a Global Effort

We can’t do it alone. That’s why we’re saying a huge thank you.

Taking on COVID-19 isn’t just a team effort — it’s also a global one. Here at Merck, we’re grateful to all the people who have worked hard to keep us safe, along with everyone around the world helping to combat the pandemic.

That’s why we’re saying thank you!

Merck and Ridgeback's Molnupiravir Receives U.S. FDA Emergency Use Authorization for the Treatment of High-Risk Adults With Mild to Moderate COVID-19

The Companies Are Committed To Providing Timely Access to Molnupiravir Through Comprehensive Supply and Access Approach

KENILWORTH, N.J. & MIAMI, December 28, 2021, /3BLMedia/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for molnupiravir, an investigational oral antiviral (MK-4482, EIDD-2801).

When the COVID-19 Pandemic Hit, Our Cafeterias Stepped up To Serve People in Need

A meal distribution program that started at the beginning of the pandemic continues to deliver thousands of meals a week to underserved communities

When the COVID-19 pandemic shuttered our offices in the spring of 2020 and thousands of employees began working remotely, our company found itself with a dilemma: lots of food in the cafeterias, but no one to eat it.

Rather than let it go to waste, Merck and FLIK Hospitality Group, our corporate dining partner, began looking for a way to put the food to use.

Merck Issues $1 Billion Inaugural Sustainability Bond

Press Release

KENILWORTH, N.J., December 13, 2021 /3BLMedia/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced its inaugural issuance of a $1 billion sustainability bond, which was part of an $8 billion underwritten public offering of notes that closed on Dec. 10, 2021.

Accelerating Global Access

Our company is collaborating with a range of partners to enable access for patients around the world
Multimedia with summary

At the outset of our research efforts for COVID-19, our company made clear its commitment to make any vaccine or medicine we develop for this pandemic broadly accessible.

Here’s how we have been working to fulfill that commitment.

All Hands on Deck Against COVID-19

How every division at Merck is pitching in to address a global need

The SARS-CoV-2 pandemic has touched everyone’s lives, and a task as monumental as fighting back against COVID-19 takes more than just one person — or even just one department. From the earliest stages of the pandemic, we knew we had a responsibility to mobilize our scientific expertise and experience to help address the pandemic.

Dedicated teams across our company have come together to respond to this unique challenge. Because a global crisis calls for a global response.

Merck Supports Hiring Our Heroes Corporate Fellowship Program

Multimedia with summary

We are proud to support the Hiring Our Heroes Corporate Fellowship Program, bringing fantastic members to our team! Learn more about our support for veterans here: http://bit.ly/3lF5iQR


Subscribe to NYSE:MRK